The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice
Article in Molecular Metabolism (August 2024)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Article in Molecular Metabolism (August 2024)
Article in Life Sciences (August 2024)
Article in Neuroscience & Biobehavioral Reviews (August 2024)